What is the appropriate starting dose of prazosin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Prazosin Starting Dose

The appropriate starting dose of prazosin is 1 mg at bedtime, regardless of indication. 1

FDA-Approved Dosing for Hypertension

The FDA drug label is explicit and unequivocal: patients should always be started on 1 mg capsules of prazosin 1. The 2 mg and 5 mg capsules are specifically not indicated for initial therapy 1. This recommendation stems from the critical safety concern of first-dose syncope, which occurs in approximately 1% of patients given an initial dose of 2 mg or greater 1.

  • Initial dose: 1 mg two or three times daily for hypertension 1
  • First-dose hypotension risk: Syncopal episodes typically occur within 30-90 minutes of the initial dose 1
  • Safety monitoring: Patients should be cautioned to avoid situations where injury could result should syncope occur during initiation 1

The 2017 ACC/AHA Hypertension Guidelines consistently cite prazosin dosing as 2-20 mg daily in 2-3 divided doses for maintenance, but this reflects therapeutic ranges after appropriate titration from the 1 mg starting dose 2, 3, 4, 5.

Dosing for PTSD-Associated Nightmares

For PTSD nightmares, the evidence strongly supports the same conservative starting approach:

  • Start at 1 mg at bedtime and increase by 1-2 mg every few days until effective dose is reached 6
  • Average effective dose: Approximately 3 mg for civilian PTSD patients 6
  • Higher doses for military veterans: Studies in combat veterans used mean doses of 9.5-13.3 mg/day, but still initiated at 1 mg 6, 7
  • Civilian trauma victims: Mean dose of 3.1 mg ± 1.3 mg was effective 7

The 2010 Best Practice Guide for Nightmare Disorder provides Level A evidence that prazosin is recommended for PTSD-associated nightmares, with treatment generally started at 1 mg at bedtime 6.

Critical Safety Considerations

Orthostatic hypotension monitoring is mandatory, particularly after the first dose 6, 1. The risk of first-dose syncope can be minimized by:

  • Limiting initial dose to 1 mg 1
  • Slow subsequent dose increases 1
  • Cautious introduction of any additional antihypertensive drugs 1
  • Patient counseling about dizziness, lightheadedness, and fall risk 1

Special Populations

Elderly or debilitated patients: Consider even lower starting doses (0.25-0.5 mg) when treating hypertension, though this is not explicitly stated in guidelines for PTSD treatment 2.

Concurrent alpha-1 antagonists: Exercise extreme caution and use individualized titration with close monitoring if the patient is on other alpha-1 antagonists like carvedilol 8.

Titration Strategy

After the 1 mg starting dose is tolerated:

  • For hypertension: Increase slowly to total daily dose of 6-15 mg in divided doses (usual therapeutic range), up to maximum 40 mg daily 1
  • For PTSD nightmares: Increase by 1-2 mg every few days based on response and tolerability 6
  • Monitor blood pressure at each dose increase, particularly in patients with cardiovascular risk factors 1

The evidence is unambiguous: 1 mg is the universal starting dose for prazosin across all indications, with careful upward titration based on response and tolerability while monitoring for orthostatic hypotension.

References

Guideline

best practice guide for the treatment of nightmare disorder in adults.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2010

Guideline

position paper for the treatment of nightmare disorder in adults: an american academy of sleep medicine position paper.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.